The University of Pittsburgh Medical Center's Inflammatory Bowel Disease Center provides specialized care for patients with ulcerative colitis and Crohn's dsease, contributes to the advancement of IBD research, and educates patients and healthcare professionals about IBD.
The IBD Center utilizes a cohesive team of physicians and surgeons, who are recognized as experts in their respective specialties. Directed by gastroenterologists who unite surgeons, nutritionists, radiologists and pathologists, the Center is designed to attract and care for a large volume of patients with IBD. In addition to providing comprehensive primary care to these patients, specific attention is also directed to cancer surveillance, women's health, intestinal rehabilitation and transplantation medicine, mental health and the transition of care from the pediatric to adult gastroenterologist. As such, care of IBD patients is integrated with the Pittsburgh Cancer Institute, Magee Women's Hospital, The Thomas E. Starzl Transplantation Institute, Western Psychiatric Institute and Clinic and Children's Hospital. By coordinating care across a variety of specialties and by providing IBD patients with "one stop shopping" for expert consultations and excellent diagnostic techniques, the Center continues to attract increasingly larger numbers of patients from the tri-state area.
The IBD Center physicians direct several multi-center, international research trials on novel IBD treatments and are respected as authorities in genetics, immunology and clinical research. Patients benefit from research advancements made by IBD Center physicians, who are some of the world's leading IBD genetics and immunology researchers.
The IBD "team" consists of the collective efforts of the following health care professionals:
This is an exciting time in the field of inflammatory bowel disease. The research advances in the fields of genetics and immunology have rendered a better understanding of the disease and offer hope to one day find a cure. The UPMC IBD Center is a nationally recognized program that provides unparalleled clinical care, offers the latest in cutting-edge research and promises to remain a leader in the field of IBD for decades to come.